| Quarter | Score |
|---|---|
| 2022-Q1 | 53.2 |
| 2022-Q3 | 67.4 |
| 2022-Q4 | 54.7 |
| 2023-Q1 | 53.1 |
| 2023-Q2 | 65.0 |
| 2023-Q3 | 48.1 |
| 2023-Q4 | 65.8 |
| 2024-Q1 | 63.3 |
| 2024-Q2 | 68.6 |
| 2024-Q3 | 57.6 |
| 2024-Q4 | 57.5 |
| 2025-Q1 | 58.8 |
| 2025-Q2 | 61.9 |
| 2025-Q3 | 61.6 |
| 2025-Q4 | 62.1 |
| 2026-Q1 | 61.8 |
| 2026-Q2 | 80.6 |
Strong consensus, but price is extended — wait for pullback to funds' basis
Trading +25.6% above funds' purchase price — elevated pullback risk
2 of 18 tracked funds hold CME. Avg conviction: 1.3%. Net adding. First tracked at $220.74 (current +25.6% vs tracked).
Baupost Group has 2.5% in this stock
Benchmark comparison unavailable
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Baupost Group | 2.5% | New Buy |
| Citadel Advisors | 0.0% | Add |